Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Caesarstone Ltd

CSTE
Current price
6.12 USD +0.15 USD (+2.51%)
Last closed 5.87 USD
Sector Industrials
Industry Building & Construction Equiment
Exchange NASDAQ
Capitalization 185 459 392 USD
Yield for 12 month +11.88 %
1Y
3Y
5Y
10Y
15Y
CSTE
21.11.2021 - 28.11.2021

Caesarstone Ltd., together with its subsidiaries, designs, develops, manufactures, and markets engineered stone and other materials under the Caesarstone brand in the United States, Canada, Latin America, Australia, Asia, Europe, the Middle East and Africa, and Israel. The company's engineered stone slabs are primarily used as indoor and outdoor kitchen countertops in the renovation and remodeling, and residential construction sectors. Its products are also used in other applications, such as vanity tops, wall panels, back splashes, floor tiles, stairs, furniture, and other interior and exterior surfaces that are used in various residential and non-residential applications. The company also offers porcelain products under the Lioli brand for countertops, flooring, and cladding applications; sells natural stone, sinks, and various ancillary fabrication tools and materials; and resells natural stones, as well as various ancillaries, and fabrication and installation accessories, as well as provides fabrication and installation services. It sells its products directly to wholesalers, resellers, and fabricators; and through direct sales force and indirect network of independent distributors. The company was formerly known as Caesarstone Sdot Yam Ltd. and changed its name to Caesarstone Ltd. in June 2016. Caesarstone Ltd. was founded in 1987 and is headquartered in Menashe, Israel. Address: Kibbutz Sdot-Yam, Menashe, Israel, 3780400

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.5 USD

P/E ratio

Dividend Yield

Current Year

+565 231 000 USD

Last Year

+690 806 000 USD

Current Quarter

+118 292 000 USD

Last Quarter

+128 525 000 USD

Current Year

+94 226 000 USD

Last Year

+163 245 000 USD

Current Quarter

+28 987 000 USD

Last Quarter

+23 280 000 USD

Key Figures CSTE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 125 000 USD
Operating Margin TTM -4.14 %
PE Ratio
Return On Assets TTM -3.85 %
PEG Ratio 1.03
Return On Equity TTM -29.52 %
Wall Street Target Price 6.5 USD
Revenue TTM 532 889 984 USD
Book Value 8.93 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -21.5 %
Dividend Yield
Gross Profit TTM 163 482 000 USD
Earnings per share -3.17 USD
Diluted Eps TTM -3.17 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY 586.9 %
Profit Margin -20.45 %

Dividend Analytics CSTE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

36 %

Dividend History CSTE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 16.08.2022
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date 07.09.2022

Stock Valuation CSTE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 8.6881
Enterprise Value Revenue 0.427
Price Sales TTM 0.3287
Enterprise Value EBITDA -4.6762
Price Book MRQ 0.5816

Financials CSTE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CSTE

For 52 weeks

3.5 USD 6.81 USD
50 Day MA 5.58 USD
Shares Short Prior Month 125 736
200 Day MA 4.65 USD
Short Ratio 0.65
Shares Short 127 738
Short Percent 0.77 %

Dynamics of changes in the value of assets

8

8011

2 450.00 JPY Sanyo Shokai Ltd 0 (0%)
Detailed analytics
K

KOSKI

7.08 EUR Koskisen -0.04 (-0.56%)
Detailed analytics
A

AKH

2.71 NOK Aker Horizons AS +0 (+0.52%)
Detailed analytics
I

IDDA

1.97 EUR INNATE PHARMA SP.ADR/1 -0.1 (-4.37%)
Detailed analytics
X

XLS

31.50 CHF Xlife Sciences AG +3.28 (+10.14%)
Detailed analytics